The emerging treatment of this peptide represents a significant development in the management of the condition. Different to existing drugs, tirzepatide targets two pathways – GLP-1 and glucose-dependent https://tirzepatidepeptide010106.blogchaat.com/42309115/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment